Neuro-Immunology: The Impact of Immune Function on Alzheimer’s Disease

Neuro-Immunology: The Impact of Immune Function on Alzheimer’s Disease

Tuesday, September 25, 2018

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

Biochemical Pharmacology Discussion Group

The New York Academy of Sciences

 

Alzheimer’s disease (AD) is a devastating neurodegenerative disorder for which there is a major unmet therapeutic need.  Limited success from current translational models and amyloid-centric clinical trials highlight the need for broader therapeutic strategies.  Looking beyond amyloid and tau as direct avenues to modify AD pathology, the field has turned to a growing body of genetic and human biology evidence that supports a role for the innate immune system as a key modifier of AD risk and progression. This one-day symposium will present recent developments in our understanding of how innate immune processes, such as those controlled by CNS-resident microglia, impact the pathobiology of AD.  Moreover, the program will explore the dynamic mechanisms at the intersection of neurology and immunology that have emerged as ‘omics technologies have supplanted classical views of neuro-inflammation, with the goal of targeting the innate immune system in the CNS for next-generation AD therapeutics.

Call for Abstracts

Abstract submissions are invited for a poster session. For complete submission instructions, please visit our online portal. The deadline for abstract submission is Friday, July 20, 2018.

Registration

Member
$60
Nonmember Academia, Faculty, etc.
$105
Nonmember Corporate, Other
$160
Nonmember Not for Profit
$105
Nonmember Student, Undergrad, Grad, Fellow
$70
Member Student, Post-Doc, Fellow
$25
Deadline:
61
days
left